JDHIF (JD Health International) ROCE %: 10.73% (As of Dec. 2025)


JDHIF JD Health International Inc JDHIF
90 GF Score
Price $5.85
GF Value $10.42
! 1 Warning Sign
View Full Analysis

What is JD Health International ROCE %?

JD Health International JDHIF 90 ROCE % is 10.73% as of Dec. 2025. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $10.42. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. JD Health International's annualized ROCE % for the quarter that ended in Dec. 2025 was 10.73%.

JD Health International  (OTCPK:JDHIF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

JD Health International ROCE % Related Terms

JD Health International ROCE % Historical Data

* Premium members only.

The historical data trend for JD Health International's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JD Health International ROCE % Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only -2.29 1.59 5.65 9.03 10.53

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.53 9.49 8.71 10.10 10.73
JDHIF
90GF Score
JD Health International Inc JDHIF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JD Health International ROCE % Calculation

JD Health International's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=857.72/( ( (9789.58 - 2131.803) + (11583.74 - 2944.885) )/ 2 )
=857.72/( (7657.777+8638.855)/ 2 )
=857.72/8148.316
=10.53 %

JD Health International's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=901.084/( ( (10926.985 - 2772.814) + (11583.74 - 2944.885) )/ 2 )
=901.084/( ( 8154.171 + 8638.855 )/ 2 )
=901.084/8396.513
=10.73 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.73% mean?
JD Health International (JDHIF) has a ROCE % of 10.73% as of Dec. 2025.
Is JD Health International's ROCE % too high?
JD Health International's current ROCE % is 10.73%. The Healthcare Providers & Services industry median ROCE % is 6.43. JD Health International's value of 10.73% is 66.9% above this industry median. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's ROCE % compare to competitors?
JD Health International's ROCE % of 10.73% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. JD Health International's value of 10.73% is 66.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current ROCE % of 10.73% is 66.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current ROCE % is 10.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current ROCE % of 10.73%. The stock's GF Value™ is $10.42, compared to a current price of $5.85 — trading 43.9% below its estimated fair value. The current ROCE % is 10.73% and 66.9% above the Healthcare Providers & Services industry median of 6.43. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For JD Health International (JDHIF), the current ROCE % is 10.73% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JD Health International (JDHIF) Overvalued in 2026?

Based on GuruFocus' analysis, JD Health International stock appears to be undervalued. The current stock price of $5.85 is trading 43.9% below its estimated GF Value™ of $10.42.

Key valuation signals for JDHIF:

  • ROCE %: 10.73%
  • GF Value™: $10.42 vs. price of $5.85 (43.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign
  • Industry Position: 66.9% above the Healthcare Providers & Services median

No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JD Health International Business Description

Address No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score

Get the complete analysis for JDHIF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.85
Price
$10.42
GF Value